Bailey D N
Department of Pathology, University of California Medical Center, San Diego 92103-8320, USA.
J Anal Toxicol. 1997 Jan-Feb;21(1):1-4. doi: 10.1093/jat/21.1.1.
The relative binding of acetaminophen, lidocaine, phenobarbital, phenytoin, quinidine, and theophylline to human tissues in vitro was studied using equilibrium dialysis. Pooled human serum plus homogenates of brain, heart, liver, and placenta were incubated at 4 degrees C with each drug at concentrations of 5 and 10 mmol/L. The percent binding of each drug to each tissue was calculated. Binding of 5% or less was considered to be negligible. By drug, the following relative binding orders were observed for those tissues demonstrating binding: acetaminophen (heart > brain, serum); lidocaine (no appreciable binding observed); phenobarbital (serum only); phenytoin (heart and liver equally; serum not studied); quinidine (serum > liver > brain, placenta); and theophylline (serum > liver). By matrix, serum bound all drugs studied except for lidocaine. Liver bound only phenytoin, quinidine, and theophylline; heart bound only acetaminophen and phenytoin; brain bound only acetaminophen and quinidine; and placenta bound only quinidine.
采用平衡透析法研究了对乙酰氨基酚、利多卡因、苯巴比妥、苯妥英、奎尼丁和茶碱在体外与人体组织的相对结合情况。将混合的人血清与脑、心脏、肝脏和胎盘的匀浆在4℃下与每种浓度为5和10 mmol/L的药物一起孵育。计算每种药物与每种组织的结合百分比。结合率为5%或更低被认为可忽略不计。按药物来看,对于显示有结合的那些组织,观察到以下相对结合顺序:对乙酰氨基酚(心脏>脑、血清);利多卡因(未观察到明显结合);苯巴比妥(仅血清);苯妥英(心脏和肝脏相同;未研究血清);奎尼丁(血清>肝脏>脑、胎盘);茶碱(血清>肝脏)。按基质来看,血清结合了除利多卡因外所有研究的药物。肝脏仅结合苯妥英、奎尼丁和茶碱;心脏仅结合对乙酰氨基酚和苯妥英;脑仅结合对乙酰氨基酚和奎尼丁;胎盘仅结合奎尼丁。